Cargando…
The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives
Discovery of antinuclear antibodies (ANA) enabled earlier diagnosis of systemic lupus erythematosus (SLE) and other ANA(+) connective tissue diseases (CTD). Rheumatologists increasingly encounter high referral volume of ANA(+) patients. It has been estimated that only a small percentage of these pat...
Autores principales: | Sternhagen, Erin, Bettendorf, Brittany, Lenert, Aleksander, Lenert, Petar S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863324/ https://www.ncbi.nlm.nih.gov/pubmed/35210816 http://dx.doi.org/10.2147/JIR.S275043 |
Ejemplares similares
-
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
por: Lenert, Aleksander, et al.
Publicado: (2017) -
Genetic load in incomplete lupus erythematosus
por: Slief, Matt, et al.
Publicado: (2023) -
Tongue necrosis as a manifestation of immune dysfunction: A complex case of systemic lupus erythematosus, histoplasmosis, and macrophage activation syndrome
por: Walsh, Madalyn, et al.
Publicado: (2023) -
Scabies, incomplete lupus erythematosus and Henoch-Schonlein purpura
por: Wu, Yang Fang, et al.
Publicado: (2021) -
Evans Syndrome in the Context of Incomplete Systemic Lupus Erythematosus
por: Abu Kar, Sarah, et al.
Publicado: (2022)